Antibody Response of Heterologous vs Homologous mRNA Vaccine Boosters Against the SARS-CoV-2 Omicron Variant: Interim Results from the PRIBIVAC Study, A Randomized Clinical Trial
SSRN Electronic Journal (2022) - Comments
doi: 10.2139/ssrn.4056669  issn: 1556-5068 

Xuan Ying Poh, Chee Wah Tan, I. Russel Lee, Jean-Marc Chavatte, Siew‐Wai Fong, Tessa Prince, Catherine Hartley, Aileen Ying-Yan Yeoh, Suma Rao, Po Ying Chia, Sean Wei Xiang Ong, Tau Hong Lee, Sapna P. Sadarangani, Ray JH Lin, Clarissa Lim, Jefanie Teo, Daniel WX Lim, Wanni Chia, Julian A. Hiscox, Lisa F.P. Ng